期刊文献+

血管内皮细胞生长因子启动子突变体萤光素酶报告基因载体的构建

Construction of a Vector of Luciferase Reporter Gene Directed by VEGF Promoter Mutant
在线阅读 下载PDF
导出
摘要 目的:构建含有不同片段血管内皮细胞生长因子(VEGF)基因的启动子的萤光素酶报告基因载体,并定位缺氧诱导因子1α(HIF-1α)结合VEGF启动子的区域。方法:以VEGF全长启动子为模板,PCR扩增VEGF启动子的不同片段,插入萤光素酶报告基因载体pGL4-basic,确定所扩增的DNA序列后,将其与HIF-1α表达载体共转染293T细胞,定位HIF-1α结合VEGF启动子的区域。结果:测序结果表明扩增的不同片段的VEGF启动子序列正确;萤光素酶活性实验表明,-1128^-728 bp片段是HIF-1α与VEGF相互作用激活VEGF启动子转录活性的区域。结论:克隆了VEGF启动子5'端缺失突变体报告基因表达载体,为调控VEGF表达的转录因子的筛选及功能研究打下了良好基础。 Objective: To clone different regions of vascular endothelial growth factor(VEGF) promoter and insert them into a luciferase reporter gene vector, and to identify the region of VEGF promoter for hypoxia inducible fac- tor-1a(HIF-1a) binding. Methods: Different regions of VEGF promoter were amplified from full length VEGF promoter by PCR and cloned into pGL4-basic. The resulting plasmids were examined by DNA sequencing. Then they were co-transfected with HIF-1a expression plasmid into 293T cell line to analyze promoter activity in the presence of HIF-1a. Results: DNA sequencing showed that the sequences of the promoter regions were correctly cloned. The region -1128~-728 bp of VEGF promoter played a major role in the interaction between HIF-1a and VEGF promoter. Conclusion: The VEGF promoter and 5 terminal deletion mutant reporter genes were cloned successfully, which will be contribute to screen transcription factors that regulate VEGF expression.
出处 《生物技术通讯》 CAS 2013年第1期37-40,共4页 Letters in Biotechnology
基金 国家自然科学基金(31071174)
关键词 血管内皮细胞生长因子 启动子 萤光素酶报告基因 转录活性 vascular endothelial growth factor promoter luciferase reporter gene transcriptional activity
  • 相关文献

参考文献10

  • 1Hanahan D,Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis[J].{H}CELL,1996,(03):353-364.
  • 2Vamesu S. Angiogenesis and tumor histologic type in primary breast cancer patients:an analysis of 155 needle core biopsies[J].{H}Romanian Journal of Morphology and Embryology,2008,(06):181-188.
  • 3Vermeulen P B,van Golen K L,Dirix L Y. Angiogene-sis,lymphangiogenesis,growth pattern,and tumor emboli in in-flammatory breast cancer:a review of the current knowledge[J].{H}CANCER,2010.2748-2754.
  • 4Cascio S,D'Andrea A,Ferla R. miR-20b modulates VEGF expression by targeting H IF-1 alpha and STAT3 in mcf-7 breast cancer cells[J].{H}Journal of Cellular Physiology,2010,(01):242-249.
  • 5Kim S E,Shirm K N,Jung S A. The clinic pathologi-cal significance of tissue levels of hypoxia-inducible factor 1alpha and vascular endothelia l growth factor in gastric can-cer[J].Gut Liver,2009,(02):88-94.
  • 6Holmquist L,Lofstedt T,Pahlman S. Effect of hypoxia on the tumor phenotype:the neuroblastoma and breast cancer models[J].{H}Advances in Experimental Medicine and Biology,2006,(04):179-193.
  • 7Zhang J,Lu A,Beech D. Suppression of breast cancer metastasis through the inhibition of VEGF-mediated tumor an-giogenesis[J].Cancer Ther,2007,(02):273-286.
  • 8Xie K P,Wei D Y,Shi Q. Constitutive and inducible expression and regulation of vascular endothelial growth factor[J].{H}Cytokine & Growth Factor Reviews,2004,(05):297-324.
  • 9Park S Y,Jiang W J,Yi E Y. Melaton in suppresses tumor angiogenesis by inhibiting HIF-1 alpha stabilization un-der hypoxia[J].{H}Journal of Pineal Research,2010,(02):178-184.
  • 10Grimshaw M J. Endothelins and hypoxia-inducible factor in cancer[J].{H}Endocrine Related Cancer,2007.233-244.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部